Sjogren’s Without Dryness? Yes, It’s a Thing
More than 10% of patients diagnosed with primary Sjögren's syndrome at a French…
Browsing Tag
Sjögrens
First-in-Class Sjogren’s Drug Passes Mid-Stage Test
MILAN -- An investigational protein drug called dazodalibep with broad-spectrum activity against autoimmune…
B-Cell Stimulating Factors Tied to Lymphoma in Sjogren’s
Genetic blood tests indicated that Bruton's tyrosine kinase (BTK) and a cytokine called…
Novel BTK Inhibitor Looks Good for Sjogren’s Syndrome
PHILADELPHIA -- Remibrutinib, an investigational Bruton's tyrosine kinase (BTK) inhibitor, appeared effective in reducing signs…
Sjogren’s Responds to Cytokine Treatment, Early Data Show
Most patients with Sjogren's syndrome treated with low doses of interleukin-2 (IL-2) in a…
Olfactory Loss Common in Sjogren’s Syndrome
Patients with Sjogren's syndrome showed significant impairments in olfactory function, Chinese…
New spontaneous mouse model shows promise for bolstering Sjögren’s syndrome…
Sjögren's syndrome is an autoimmune disease that attacks the tear system in the eyes and salivary glands, leading to patients experiencing extremely dry eyes and mouth. Current treatment…